I have to agree with Wedbush's comments. Trubion is definitely a company under the radar right now, very little volume on this name.
- 60 million in cash with a 77 million dollar market cap - Strong Partnership with Wyeth / Pfizer (CD-20) - Strong Partnership with Facet (CD-37) - Very Interesting novel Ab scaffold tech platform play (SMIP and Scorpion) - Strong mgmt team
Jan '10 investor presentation (on website) was impressive.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.